It should be considered that performing SNP analysis may have an advantage over simply measuring CRP or IL-1β levels because its determination is independent of the patient’s current status (presence of inflammation unrelated to cancer and/or the development of other diseases, nutrition, comorbidities, previous treatment affecting the immune system, etc.). Here, CRP is linked to cancer.